» Articles » PMID: 18537267

Quantification of the Thermodynamically Linked Quaternary and Tertiary Structural Stabilities of Transthyretin and Its Disease-associated Variants: the Relationship Between Stability and Amyloidosis

Overview
Journal Biochemistry
Specialty Biochemistry
Date 2008 Jun 10
PMID 18537267
Citations 66
Authors
Affiliations
Soon will be listed here.
Abstract

Urea denaturation studies were carried out as a function of transthyretin (TTR) concentration to quantify the thermodynamically linked quaternary and tertiary structural stability and to improve our understanding of the relationship between mutant folding energetics and amyloid disease phenotype. Urea denaturation of TTR involves at least two equilibria: dissociation of tetramers into folded monomers and monomer unfolding. To deal with the thermodynamic linkage of these equilibria, we analyzed concentration-dependent denaturation data by globally fitting them to an equation that simultaneously accounts for the two-step denaturation process. Using this method, the quaternary and tertiary structural stabilities of well-behaved TTR sequences, wild-type (WT) TTR and the disease-associated variant V122I, were scrutinized. The V122I variant is linked to late onset familial amyloid cardiomyopathy, the most common familial TTR amyloid disease. V122I TTR exhibits a destabilized quaternary structure and a stable tertiary structure relative to those of WT TTR. Three other variants of TTR were also examined, L55P, V30M, and A25T TTR. The L55P mutation is associated with the most aggressive familial TTR amyloid disease. L55P TTR has a complicated denaturation pathway that includes dimers and trimers, so globally fitting its concentration-dependent urea denaturation data yielded error-laden estimates of stability parameters. Nevertheless, it is clear that L55P TTR is substantially less stable than WT TTR, primarily because its tertiary structure is unstable, although its quaternary structure is destabilized as well. V30M is the most common mutation associated with neuropathic forms of TTR amyloid disease. V30M TTR is certainly destabilized relative to WT TTR, but like L55P TTR, it has a complex denaturation pathway that cannot be fit to the aforementioned two-step denaturation model. Literature data suggest that V30M TTR has stable quaternary structure but unstable tertiary structure. The A25T mutant, associated with central nervous system amyloidosis, is highly aggregation-prone and exhibits drastically reduced quaternary and tertiary structural stabilities. The observed differences in stability among the disease-associated TTR variants highlight the complexity and heterogeneity of TTR amyloid disease, an observation that has important implications for the treatment of these maladies.

Citing Articles

Aggregation of Transthyretin by Fluid Agitation.

Ritsch I, Dyson H, Wright P bioRxiv. 2024; .

PMID: 39605681 PMC: 11601261. DOI: 10.1101/2024.11.08.622726.


Mispacking of the F87 sidechain drives aggregation-promoting conformational fluctuations in the subunit interfaces of the transthyretin tetramer.

Sun X, Ferguson J, Yang K, Stanfield R, Dyson H, Wright P Protein Sci. 2024; 33(9):e5101.

PMID: 39149996 PMC: 11327909. DOI: 10.1002/pro.5101.


Conservation of kinetic stability, but not the unfolding mechanism, between human transthyretin and a transthyretin-related enzyme.

Jager M, Kelly J, Gruebele M Proc Natl Acad Sci U S A. 2024; 121(34):e2315007121.

PMID: 39133861 PMC: 11348317. DOI: 10.1073/pnas.2315007121.


Cryo-EM confirms a common fibril fold in the heart of four patients with ATTRwt amyloidosis.

Nguyen B, Singh V, Afrin S, Singh P, Pekala M, Ahmed Y Commun Biol. 2024; 7(1):905.

PMID: 39068302 PMC: 11283564. DOI: 10.1038/s42003-024-06588-6.


Conformational Dynamics of an Amyloidogenic Intermediate of Transthyretin: Implications for Structural Remodeling and Amyloid Formation.

Leach B, Ferguson J, Morgan G, Sun X, Kroon G, Oyen D J Mol Biol. 2024; 436(16):168673.

PMID: 38909653 PMC: 11410348. DOI: 10.1016/j.jmb.2024.168673.


References
1.
Sekijima Y, Hammarstrom P, Matsumura M, Shimizu Y, Iwata M, Tokuda T . Energetic characteristics of the new transthyretin variant A25T may explain its atypical central nervous system pathology. Lab Invest. 2003; 83(3):409-17. DOI: 10.1097/01.lab.0000059937.11023.1f. View

2.
Jacobson D, McFarlin D, Kane I, Buxbaum J . Transthyretin Pro55, a variant associated with early-onset, aggressive, diffuse amyloidosis with cardiac and neurologic involvement. Hum Genet. 1992; 89(3):353-6. DOI: 10.1007/BF00220559. View

3.
Kelly J . Alternative conformations of amyloidogenic proteins govern their behavior. Curr Opin Struct Biol. 1996; 6(1):11-7. DOI: 10.1016/s0959-440x(96)80089-3. View

4.
Colon W, Kelly J . Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro. Biochemistry. 1992; 31(36):8654-60. DOI: 10.1021/bi00151a036. View

5.
Jiang X, Smith C, Petrassi H, Hammarstrom P, White J, Sacchettini J . An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured. Biochemistry. 2001; 40(38):11442-52. DOI: 10.1021/bi011194d. View